Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine

DOI 10.1038/nm.3855

Cited by (686)

Items 301–400 of 686

Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma
Erica A. Power, Jenelys Fernandez-Torres, Liang Zhang, Ruiyi Yaun, Fabrice Lucien, David J. Daniels · 2022 · PLoS ONE
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
Cheng Xu, Heng Liu, Christopher J. Pirozzi, Lee H. Chen, Paula K. Greer, Bill H. Diplas, Liwei Zhang, Matthew S. Waitkus, Yiping He, Hai Yan · 2021 · Acta Neuropathologica Communications
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials
Ruman Rahman, Mirosław Janowski, Clare L. Killick-Cole, William Singleton, Emma L. Campbell, Piotr Walczak, Soumen Khatua, Lukas Faltings, Marc H. Symons, Julia R. Schneider et al. · 2023 · Cancers
Oncohistones in brain tumors: the soil and seed
Augusto Faria Andrade, Carol C. L. Chen, Nada Jabado · 2023 · Trends in cancer
Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Cavan P. Bailey, Mary Figueroa, Sana Mohiuddin, Wafik Tharwat Zaky, Joya Chandra · 2018 · Bioengineering
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Noah Berlow, Rishi Raj Rikhi, Mathew N. Geltzeiler, Jinu Abraham, Matthew N. Svalina, Lara Emily Davis, Erin Wise, Maria Mancini, Jonathan Christopher Noujaim, Atiya Mansoor et al. · 2019 · BMC Cancer
Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?
Niveditha Manjunath, Prerana Jha, Jyotsna Singh, Amol Raheja, Kavneet Kaur, Ashish Suri, Ajay Kumar Garg, Mehar Chand Sharma, Chitra Sarkar, Madan Mohan et al. · 2020 · Neurological Sciences
Systematic identification of biomarker-driven drug combinations to overcome resistance
Matthew G. Rees, Lisa Brenan, Mariana DoCarmo, Patrick Duggan, Besnik Bajrami, Michael Arciprete, Andrew S. Boghossian, Emma W Vaimberg, Steven J. Ferrara, Timothy A. Lewis et al. · 2022 · Nature Chemical Biology
Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors
Lin Qi, Mari Kogiso, Yuchen Du, Huiyuan Zhang, Frank Braun, Yulun Huang, Wan‐Yee Teo, Holly Lindsay, Sibo Zhao, Patricia Ann Baxter et al. · 2020 · Cancer Letters
Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Hsiao P. J. Voon, Linda L. Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison E. Morey, Toby D. M. Bell et al. · 2023 · Genome biology
Pineal region glioblastomas display features of diffuse midline and non-midline gliomas
Randy S. D’Amico, George J. Zanazzi, Peter B. Wu, Peter Canoll, Jeffrey N. Bruce · 2018 · Journal of Neuro-Oncology
Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth
Katie F. Loveson, Helen L. Fillmore · 2018 · Brain Sciences
Pediatric Brain Tumors
Sonia Partap, Michelle Monje · 2020 · CONTINUUM Lifelong Learning in Neurology
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas
Lindsay Baker Kilburn, Mehmet Koçak, Patricia Ann Baxter, Tina Young Poussaint, Arnold C. Paulino, Christine McIntyre, Annabelle Lemenuel‐Diot, Christine Lopez‐Diaz, Larry E. Kun, Murali Chintagumpala et al. · 2017 · Pediatric Blood & Cancer
Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors
Anshuman Dasgupta, Jan‐Niklas May, Geir Klinkenberg, Helena C. Besse, Eva Miriam Buhl, Diana Moeckel, Rahaf Mihyar, Quim Peña, Armin Azadkhah Shalmani, Christopher Hark et al. · 2025 · Journal of Controlled Release
Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma
Wei Li, Fei He, Wen Zhang, Wen‐Hua Chen, Bo Yu · 2018 · Biological Research
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy
Raymond Y. Chang, Umberto Tosi, Julia C. Voronina, Oluwaseyi O. Adeuyan, Linda Y. Wu, Melanie E. Schweitzer, David J. Pisapia, Oren Josh Becher, Mark M. Souweidane, Uday Bhanu Maachani · 2019 · Neuro-Oncology Advances
The intersect of neurosurgery with diffuse intrinsic pontine glioma
Claudia M. Kuzan-Fischer, Mark M. Souweidane · 2019 · Journal of Neurosurgery Pediatrics
The growing role of epigenetics in childhood cancers
Eshini Panditharatna, Mariella G. Filbin · 2019 · Current Opinion in Pediatrics
Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine
Adam L. Green, Patrick C. Flannery, Todd Cameron Hankinson, Brent R. O’Neill, Vladimir M. Amani, John A. DeSisto, Aaron J. Knox, Hannah V. Chatwin, Rakeb Lemma, Lindsey Marie Hoffman et al. · 2020 · Neuro-Oncology Advances
Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
Zirong Chen, Peng Peng, Xiaolin Zhang, Barbara L. Mania-Farnell, Guifa Xi, Feng Wan · 2021 · Cancers
Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas
Sibo Zhao, Jia Li, Huiyuan Zhang, Lin Qi, Yuchen Du, Mari Kogiso, Frank Braun, Sophie Xiao, Yulun Huang, Jianfang Li et al. · 2022 · Nature Communications
Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors
Bernard Lawrence Marini, Lydia L. Benitez, Andrew H. Zureick, Ralph Salloum, Angela C. Gauthier, Julia M. Brown, Yi-Mi Wu, Dan R. Robinson, Chandan Kumar‐Sinha, Robert J. Lonigro et al. · 2017 · Translational research
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors
Carl Johannes Koschmann, Yi‐Mi Wu, Chandan Kumar‐Sinha, Robert J. Lonigro, Pankaj Vats, Katayoon Kasaian, Marcin P. Cieslik, Xuhong Cao, Bailey Anderson, Kevin M. Frank et al. · 2018 · JCO Precision Oncology
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Thomas K. Sears, Craig Horbinski, Kevin Woolard · 2021 · Journal of Neuro-Oncology
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma
Oluwaseun Oluwadara Akinduro, Diogo P. Moniz Garcia, Dominique M. O. Higgins, Tito G M Vivas-Buitrago, Mark E. Jentoft, David A. Solomon, David J. Daniels, Zach A. Pennington, Wendy J. Sherman, Mychael W. Delgardo et al. · 2021 · Journal of Neurosurgery Spine
Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature
Ashley L. B. Raghu, Jason Chen, Pablo Andres Valdes, Walid Ibn Essayed, Elizabeth B. Claus, Omar M. Arnaout, Timothy Richard Smith, Ennio Antonio Chiocca, Pier Paolo Peruzzi, Joshua D. Bernstock · 2022 · Cancers
Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma
Jiyoon Park, Chan Chung · 2023 · Brain Tumor Research and Treatment
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Erik R. Peterson, Peter Sajjakulnukit, Andrew J. Scott, Caleb Heaslip, Anthony C. Andren, Kari Wilder-Romans, Weihua Zhou, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin et al. · 2024 · Cancer & Metabolism
Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities
Yusha Y. Sun, Cavan P. Bailey, Zsila Sousan Sadighi, Wafik Tharwat Zaky, Joya Chandra · 2020 · Journal of Neuro-Oncology
Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma
Daniel A.R. Heisey, Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert, Mayuri Shende, Yuki Kato Maves, Jennifer E. Koblinski, Mikhail G. Dozmorov et al. · 2021 · Molecular Cancer Therapeutics
Fifty years of DIPG: looking at the future with hope
Umberto Tosi, Mark M. Souweidane · 2023 · Child s Nervous System
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
Kirti Pandey, Stacie Shiqi Wang, Nicole A. Mifsud, Pouya Faridi, Alexander J. Davenport, Andrew Ian Webb, Jarrod John Sandow, Rochelle Ayala, Michelle Monje, Ryan Stanley Cross et al. · 2023 · Frontiers in Oncology
H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions
Leo F. Nonnenbroich, Samantha M. Bouchal, Elena Millesi, Julian S. Rechberger, Soumen Khatua, David J. Daniels · 2024 · Cells
Exploration of novel 5′(7′)-substituted-2′-oxospiro[1,3]dioxolane-2,3′-indoline-based N -hydroxypropenamides as histone deacetylase inhibitors and antitumor agents
Do Thi Mai Dung, Phan Thị Phương Dung, Dao Thi Kim Oanh, Tran Khac Vu, Hyunggu Hahn, Byung Woo Han, Minji Pyo, Young Guk Kim, Sang‐Bae Han, Nguyen‐Hai Nam · 2015 · Arabian Journal of Chemistry
Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System
Miguel Marigil, Naiara Martínez-Vélez, Pablo Daniel Domínguez, Miguel Angel Idoate, Enric Xipell, Ana Patiño‐García, Marisol González-Huarriz, Marc García-Moure, Marie‐Pierre Junier, Hervé Chneiweiss et al. · 2017 · PLoS ONE
Molecular foundations of primary spinal tumors—implications for surgical management
Tej Deepak Azad, Bowen Jiang, Chetan Bettegowda · 2019 · Annals of Translational Medicine
A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival
Cláudia C.S. Evangelista, Emilie Barret, Virginie Ménez, Jane Merlevede, Thomas Kergrohen, Ambre Saccasyn, Estelle Oberlin, Stéphanie Puget, Kévin Beccaria, Jacques Grill et al. · 2019 · Oncogene
Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma
Louis T. Rodgers, Cynthia Lester McCully, Arman Odabas, Rafael Cruz, Cody J. Peer, William Douglas Figg, Katherine E. Warren · 2020 · Cancer Chemotherapy and Pharmacology
17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma
Shivendra Vikram Singh, Ahmed Abu‐Zaid, Wenwei Lin, Jonathan A. Low, Alireza Abdolvahabi, Hongjian Jin, Qiong Wu, Bailey Cooke, Jie Fang, John J. Bowling et al. · 2020 · iScience
Diffuse intrinsic pontine gliomas: Diagnostic approach and treatment strategies
M. Burhan Janjua, Vin Shen Ban, Tarek Youssef El Ahmadieh, Steven Wei-Hung Hwang, Amer F. Samdani, Angela V. Price, Bradley E. Weprin, H. Hunt Batjer · 2019 · Journal of Clinical Neuroscience
Rapid and fulminant leptomeningeal spread following radiotherapy in diffuse intrinsic pontine glioma
Christopher L. Tinkle, Brent A. Orr, John Thomas Lucas, Paul D. Klimo, Zoltan J Patay, Suzanne J. Baker, Alberto Broniscer, Ibrahim A. Qaddoumi · 2017 · Pediatric Blood & Cancer
The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel
Paul Huchedé, Pierre Leblond, Marie Castets · 2022 · Biomedicines
Advances on Epigenetic Drugs for Pediatric Brain Tumors
Panagiotis Skouras, Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · Current Neuropharmacology
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
Alyssa Noll, Carrie H. Myers, Matthew C. Biery, Michael Meechan, Sophie Tahiri, Asmitha Rajendran, Michael E. Berens, Danyelle Paine, Sara Ann Byron, Jiaming Zhang et al. · 2023 · Neoplasia
Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway
Xiufen Liu, Qi Zhou, Raffit Hassan, Ira H Pastan · 2017 · Oncotarget
Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance
Thamara J. Abouantoun, Javad Nazarian, Anthony Ghanem, Stanislav Vukmanović, Anthony David Sandler · 2018 · PLoS ONE
Chromatin remodeling defects in pediatric brain tumors
Αλεξία Κλώνου, Danai Spiliotakopoulou, Marios S. Themistocleous, Christina Piperi, Athanasios G. Papavassiliou · 2018 · Annals of Translational Medicine
Histone H3K27M Mutation in Brain Tumors
Ahmed H. K. El-Hashash · 2020 · Advances in experimental medicine and biology
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases
Zhihong J. Wang, Yubin Ge, Deniz Altınok, Janet M. Poulik, Sandeep Sood, Jeffrey Warren Taub, Holly J. Edwards, Mark W. Kieran, Miller Steven · 2017 · Journal of Pediatric Hematology/Oncology
An efficient method for the transduction of primary pediatric glioma neurospheres
Michaël Hananja Meel, Dennis Serge Metselaar, Piotr Waranecki, Gertjan J.L. Kaspers, Esther Hulleman · 2018 · MethodsX
Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report
Elena I. Fomchenko, Zeynep Erson-Omay, Adam J. Kundishora, Christopher S. Hong, Ava A. Daniel, August A. Allocco, Phan Q. Duy, Armine Darbinyan, Asher M. Marks, Michael L. DiLuna et al. · 2020 · Journal of Neurosurgery Pediatrics
HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53
Caroline Capdevielle, Angélique Desplat, Justine Charpentier, Francis A. Sagliocco, Pierre Thiébaud, Nadine Thézé, Sandrine Fédou, Katarzyna B. Hooks, Romano Silvestri, Veronique Guyonnet‐Dupérat et al. · 2019 · Neuro-Oncology
Radiotherapy and radio‐sensitization in H3K27M ‐mutated diffuse midline gliomas
Chao Liu, Shuwen Kuang, Lei Wu, Quan Cheng, Xuan Gong, Jun Wu, Longbo Zhang · 2023 · CNS Neuroscience & Therapeutics
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma
Kinjal Desai, Siyi Wanggou, Erika Luis, Heather Whetstone, Chunying Yu, Robert J. Vanner, Hayden J. Selvadurai, Lilian Lee, Jinchu Vijay, Julia E. Jaramillo et al. · 2025 · Nature Communications
REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature
Shavali Shaik, Bridget A. Kennis, Shinji Maegawa, Keri Schadler, Yang Yanwen, Keri Callegari, Rishi Ramesh Lulla, Stewart Goldman, Javad Nazarian, Veena Rajaram et al. · 2017 · Oncotarget
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
Ziv Versano, Eitan Shany, Shany Freedman, Liron Tuval-Kochen, Moshe Leitner, Shoshana Paglin, Amos Toren, Michal Yalon · 2018 · Oncotarget
The 100 most-cited articles about diffuse intrinsic pontine glioma: a bibliometric analysis
Victor M. Lu, Erica A. Power, Panogiotis Kerezoudis, David J. Daniels · 2019 · Child s Nervous System
Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors
Julia Alejandra Pezuk, Karina Bezerra Salomão, Mirella Baroni, Carolina Alves Pereira Corrêa, Lenisa Geron, María Sol Brassesco · 2019 · Cancer and Metastasis Reviews
Cardiac Safety of Kinase Inhibitors – Improving Understanding and Prediction of Liabilities in Drug Discovery Using Human Stem Cell-Derived Models
Ricarda Ziegler, Fabian Häusermann, Stephan Kirchner, Liudmila Polonchuk · 2021 · Frontiers in Cardiovascular Medicine
Laminin-associated integrins mediate Diffuse Intrinsic Pontine Glioma infiltration and therapy response within a neural assembloid model
Sauradeep Sinha, Michelle S. Huang, Georgios Mikos, Yudhishtar S. Bedi, Luis Antonio Cruz Soto, Sarah Lensch, Manish Ayushman, Lacramioara Bintu, Nidhi Bhutani, Sarah C. Heilshorn et al. · 2024 · Acta Neuropathologica Communications
Convection-Enhanced Delivery in Children: Techniques and Applications
Kristian Aquilina, Anupam Chakrapani, Lucinda Carr, Manju A. Kurian, Darren R. Hargrave · 2022 · Advances and technical standards in neurosurgery
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
Guohao Liu, Yanmei Qiu, Po Zhang, Zirong Chen, Sui Chen, Weida Huang, Baofeng Wang, Xingjiang Yu, Dongsheng Guo · 2022 · Pharmaceutics
Combination therapy design for maximizing sensitivity and minimizing toxicity
Kevin Matlock, Noah Berlow, Charles Keller, Ranadip Pal · 2017 · BMC Bioinformatics
Prolonged survival in a patient with a cervical spine H3K27M-mutant diffuse midline glioma
Kelsey Peters, Drew W. Pratt, Carl Johannes Koschmann, Denise Leung · 2019 · BMJ Case Reports
Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas
Madhuri Kambhampati, Eshini Panditharatna, Sridevi Yadavilli, Karim Saoud, Sulgi Lee, Augustine Eze, M. Isabel Almira-Suarez, Lauren E. Hancock, Erin R. Bonner, Jamila Gittens et al. · 2020 · Scientific Reports
Combinatorial Intracellular Delivery Screening of Anticancer Drugs
Belén Sola-Barrado, Diana M. Leite, Edoardo Scarpa, Aroa Duro‐Castaño, Giuseppe Battaglia · 2020 · Molecular Pharmaceutics
Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
Yuchen Zhong, Chaojing Zheng, Weiyuan Zhang, Hongyu Wu, Meng Wang, Qian Zhang, Haiyang Feng, Guiyu Wang · 2023 · Frontiers in Immunology
Diffuse Midline Gliomas: Challenges and New Strategies in a Changing Clinical Landscape
Umberto Tosi, Mark M. Souweidane · 2024 · Cancers
H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells
Katarzyna B. Leszczyńska, Amanda Freitas-Huhtamäki, Chinchu Jayaprakash, Monika Dźwigońska, Francisca N. de Luna Vitorino, Cynthia Horth, Kamil Wojnicki, Bartłomiej Gielniewski, Paulina Szadkowska, Beata Kaza et al. · 2024 · Cell Reports
EZHIP’s role in diffuse midline glioma: echoes of oncohistones?
Afraah Cassim, Matthew D. Dun, David Gallego‐Ortega, Fátima Valdés‐Mora · 2024 · Trends in cancer
Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery
Ranjodh Singh, Vanessa Bellat, Melinda Wang, Melanie E. Schweitzer, Linda Y. Wu, Ching‐Hsuan Tung, Mark M. Souweidane, Benedict Law · 2017 · Journal of neurosurgery
Diffuse Intrinsic Pontine Gliomas Exhibit Cell Biological and Molecular Signatures of Fetal Hindbrain-Derived Neural Progenitor Cells
Yu Sun, Cheng Xu, Changcun Pan, Xin Chen, Yibo Geng, Yuliang Wu, Peng Zhang, Wenhao Wu, Yu Wang, Deling Li et al. · 2019 · Neuroscience Bulletin
Identification of a differentiation stall in epithelial mesenchymal transition in histone H3–mutant diffuse midline glioma
Lauren Sanders, Allison R. Cheney, Lucas Seninge, Anouk van den Bout, Marissa Chen, Holly C. Beale, Ellen Towle Kephart, Jacob Pfeil, Katrina Learned, A. Geoffrey Lyle et al. · 2020 · GigaScience
Epigenetic mechanisms in paediatric brain tumours: regulators lose control
Sara Badodi, Silvia Marino · 2022 · Biochemical Society Transactions
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
Julian S. Rechberger, Kendra A. Porath, Liang Zhang, Cody L. Nesvick, Randy S. Schrecengost, Jann Nagina Sarkaria, David J. Daniels · 2022 · Pharmaceutics
Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system
María Belén Garcia-Fabiani, Andrea Comba, Padma Kadiyala, Santiago Haase, Felipe Javier Núñez, David B. Altshuler, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology
Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
Miriam Bornhorst, Eugene I. Hwang · 2019 · Pediatric Drugs
Restoration of H3k27me3 Modification Epigenetically Silences Cry1 Expression and Sensitizes Leptin Signaling to Reduce Obesity‐Related Properties
Wei Xing Yan, Jun Chen, Xing Yue Xu, Li Fan, Kun Wu, Yingying Jiang, Yuqing Rao, Chen Zhao, Wantao Chen, Xu Wang · 2021 · Advanced Science
Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
Anne C. Harttrampf, Maria Eugénia Marques Da Costa, Aline Renoult, Estelle Daudigeos‐Dubus, Birgit Geoerger · 2021 · BMC Cancer
Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers
Felice Giangaspero, Francesca Gianno, Manila Antonelli, Elisabetta Ferretti, Maura Massimino, Antonietta Arcella · 2018 · Glioma
Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence
Monika Sharma, Ivana Barravecchia, Robert Teis, Jeanette Cruz, Rachel A. Mumby, Elizabeth K. Ziemke, Carlos E. Espinoza, Varunkumar Krishnamoorthy, Brian Magnuson, Mats E. Ljungman et al. · 2023 · Molecular Cancer Therapeutics
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D.J. Pearson, Sabine C. Mueller, Mariella G. Filbin, Jacques Grill, Cynthia E Hawkins, Chris Jones, Martha Boeri Donoghue, Nicole Lauren Drezner, Susan L. Weiner, Mark Russo et al. · 2025 · European Journal of Cancer
Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors
Andrea Timpanaro, Edward Z. Song, Nour Emwas, Chu-Hsuan Chiu, Rebecca J. Ronsley, Mallory R. Taylor, Jessica Foster, Leo David Wang, Nicholas Alexander Vitanza · 2025 · Cancer Discovery
Biopsy for diffuse intrinsic pontine glioma: a reappraisal
Mark W. Kieran, Liliana Christova Goumnerova, Michael D. Prados, Nalin M. Gupta · 2016 · Journal of Neurosurgery Pediatrics
Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review
Sana Mohiuddin, Stefania Maraka, Muhammad Usman Baig, Sumit Kumar Gupta, Tariq Muzzafar, Tibor Vályi-Nagy, Holly Lindsay, Karen M. Moody, Shehla Razvi, Arnold C. Paulino et al. · 2021 · Journal of Clinical Neuroscience
Successful Strategies in the Discovery of Small-Molecule Epigenetic Modulators with Anticancer Potential
Juan Bayo, Maithili P. Dalvi, Elisabeth D. Martínez · 2015 · Future Medicinal Chemistry
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine‐based Histone Deacetylase Inhibitors
Hazem Abdelkarim, Raghupathi Neelarapu, Antonett Madriaga, Aditya Sudheer Vaidya, Irida Kastrati, Bhargava Karumudi, Yue‐ting Wang, Taha Y. Taha, Gregory R. J. Thatcher, Jonna M. Frasor et al. · 2017 · ChemMedChem
Oxaliplatin and [Pt( R , R -DACH)(panobinostat -2H )] show nanomolar cytotoxicity towards diffuse intrinsic pontine glioma (DIPG)
Marie H. C. Boulet, Laura K. Marsh, Alison Howarth, Alice Woolman, Nicola J. Farrer · 2020 · Dalton Transactions
Genome Medicine for Brain Tumors: Current Status and Future Perspectives
Akitake Mukasa · 2020 · Neurologia medico-chirurgica
OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes
Yunfei Liao, Zaili Luo, Yaqi Deng, Feng Zhang, Rohit Rao, Jiajia Wang, Lingli Xu, Shiva Senthil Kumar, Satarupa Sengupta, Mariko D DeWire-Schottmiller et al. · 2021 · Neuro-Oncology
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors—Histone Mutated Midline Glioma Workshop Proceedings*
Brett James Theeler, Yamini Dalal, Michelle Monje, Ali Shilatifard, Mario L. Suvà, Orwa Aboud, Kevin A. Camphausen, Christine Cordova, Elizabeth Finch, John D. Heiss et al. · 2020 · Neuro-Oncology Advances
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Siva Kumar Natarajan, Matthew J Pun, James Haggerty-Skeans, Sriram Venneti · 2025 · Annual Review of Pathology Mechanisms of Disease
Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models
Huiyuan Zhang, Yuchen Du, Lin Qi, Sophie Xiao, Frank Braun, Mari Kogiso, Yulun Huang, Frank Huang, Aalaa Sanad Abdallah, Milagros Suárez et al. · 2023 · Journal of Translational Medicine
An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect
Farah Rahal, Caroline Capdevielle, Benoit Rousseau, Julien Izotte, Jean‐William Dupuy, David Cappellen, Guillaume Chotard, Mélissa Ménard, Justine Charpentier, Vincent Jecko et al. · 2022 · Neuro-Oncology Advances
Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
Mariam Markouli, Dimitrios Strepkos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2022 · Cancers
The current state of glioma data registries
Alexander G. Yearley, Julian Bryan Iorgulescu, Ennio Antonio Chiocca, Pier Paolo Peruzzi, Timothy Richard Smith, David A. Reardon, Michael A. Mooney · 2022 · Neuro-Oncology Advances
Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
Andrew P. Groves, Tabitha M. Cooney · 2022 · Frontiers in Cell and Developmental Biology
Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas
Esther P. Jane, Matthew C. Reslink, Taylor A. Gatesman, Matthew E. Halbert, Tracy A. Miller, Brian J. Golbourn, Stephanie M. Casillo, Steven J. Mullett, Stacy Gelhaus Wendell, Udochukwu C. Obodo et al. · 2023 · Molecular Oncology
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma
Noah Berlow, Catherine S. Grasso, Michael J. Quist, Mingshan Cheng, Regina F. Gandour‐Edwards, Brian S. Hernandez, Joel Edmund Michalek, Christopher W. Ryan, Paul T. Spellman, Ranadip Pal et al. · 2020 · Sarcoma